A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts
文献类型:期刊论文
作者 | Zhang, Bingjie5; Zhao, Simeng5; Yang, Dehua2,3; Wu, Yiran5; Xin, Ye5; Cao, Haijie5; Huang, Xi-Ping4; Cai, Xiaoqing2,3; Sun, Wen2,3,6; Ye, Na7,8 |
刊名 | ACS CENTRAL SCIENCE |
出版日期 | 2020-02-26 |
卷号 | 6期号:2页码:213-225 |
ISSN号 | 2374-7943 |
DOI | 10.1021/acscentsci.9b01125 |
通讯作者 | Zhong, Guisheng() ; Wang, Ming-Wei(mwwang@simm.ac.cn) ; Shui, Wenqing(shuiwq@shanghaitec.edu.cn) |
英文摘要 | Subtype selectivity and functional bias are vital in current drug discovery for G protein-coupled receptors (GPCRs) as selective and biased ligands are expected to yield drug leads with optimal on-target benefits and minimal side-effects. However, structure-based design and medicinal chemistry exploration remain challenging in part because of highly conserved binding pockets within subfamilies. Herein, we present an affinity mass spectrometry approach for screening herbal extracts to identify active ligands of a GPCR, the 5-HT2C receptor. Using this method, we discovered a naturally occurring aporphine 1857 that displayed strong selectivity for activating 5-HT2C without activating the 5-HT2A or 5-HT2B receptors. Remarkably, this novel ligand exhibited exclusive bias toward G protein signaling for which key residues were identified, and it showed comparable in vivo efficacy for food intake suppression and weight loss as the antiobesity drug, lorcaserin. Our study establishes an efficient approach to discovering novel GPCR ligands by exploring the largely untapped chemical space of natural products. |
WOS关键词 | 5-HT2C RECEPTOR ; MASS-SPECTROMETRY ; FUNCTIONAL SELECTIVITY ; CRYSTAL-STRUCTURE ; NATURAL-PRODUCTS ; OPIOID RECEPTOR ; DRUG DISCOVERY ; SEROTONIN ; LORCASERIN ; LIGANDS |
资助项目 | National Key R&D Program of China[2018YFA0507000] ; National Key R&D Program of China[2018YFA0507004] ; National Key R&D Program of China[2016YFC0905900] ; National Key R&D Program of China[2017YFC1001300] ; National Mega R&D Program for Drug Discovery grants[2018ZX09711002-002-005] ; National Mega R&D Program for Drug Discovery grants[2018ZX09735-001] ; National Natural Science Foundation of China[31971362] ; National Natural Science Foundation of China[81773792] ; National Natural Science Foundation of China[31771130] ; Novo Nordisk-CAS Research Fund grant 2017 ; Novo Nordisk-CAS Research Fund grant 2019 ; ShanghaiTech University |
WOS研究方向 | Chemistry |
语种 | 英语 |
出版者 | AMER CHEMICAL SOC |
WOS记录号 | WOS:000517832800016 |
源URL | [http://119.78.100.183/handle/2S10ELR8/281260] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Zhong, Guisheng; Wang, Ming-Wei; Shui, Wenqing |
作者单位 | 1.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China 2.Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China 4.Univ N Carolina, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Sch Med, Chapel Hill, NC 27599 USA 5.ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China 6.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 7.Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Peoples R China 8.Soochow Univ, Coll Pharmaceut Sci, Suzhou 215123, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Bingjie,Zhao, Simeng,Yang, Dehua,et al. A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts[J]. ACS CENTRAL SCIENCE,2020,6(2):213-225. |
APA | Zhang, Bingjie.,Zhao, Simeng.,Yang, Dehua.,Wu, Yiran.,Xin, Ye.,...&Shui, Wenqing.(2020).A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts.ACS CENTRAL SCIENCE,6(2),213-225. |
MLA | Zhang, Bingjie,et al."A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts".ACS CENTRAL SCIENCE 6.2(2020):213-225. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。